Paclitaxel protein-bound Intravenous and Trelegy Ellipta

• Generic Name: paclitaxel protein-bound
• Dosage Forms: n.a.
• Other Brand Names: Abraxane

Paclitaxel protein-bound injection is used to treat metastatic breast cancer (cancer that has already spread) after other treatments have failed. It is used together with carboplatin, a cancer medicine, to treat advanced or metastatic non-small cell lung cancer in patients who cannot receive radiation therapy or have surgery. Paclitaxel protein-bound is used together with gemcitabine, a cancer medicine, to treat metastatic pancreas cancer.

Paclitaxel belongs to the group of medicines called antineoplastics (cancer medicines). It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal body cells may also be affected by paclitaxel, other unwanted effects will also occur.

Paclitaxel protein-bound is to be given only by or under the direct supervision of a doctor.

• Generic Name: fluticasone / umeclidinium / vilanterol
• Dosage Forms: inhalation powder
• Other Brand Names: Trelegy Ellipta

Trelegy Ellipta is an inhalation powder containing a combination of fluticasone, umeclidinium, and vilanterol. Fluticasone is a steroid that prevents the release of substances in the body that cause inflammation.

Umeclidinium is an anticholinergic. Vilanterol is a bronchodilator. These medications work by relaxing muscles in the airways to improve breathing.

Trelegy Ellipta is used to improve symptoms and prevent bronchospasm in adults with COPD (chronic obstructive pulmonary disease), including bronchitis and emphysema.

Trelegy Ellipta may also be used for purposes not listed in this medication guide.